Medtronic Plc [MDT] stock is trading at $85.25, up 4.23%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MDT shares have gain 6.78% over the last week, with a monthly amount glided 2.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on October 10, 2024, when RBC Capital Mkts upgraded its rating to a Outperform and also boosted its price target to $105 from $98. Previously, Oppenheimer reaffirmed its Perform rating on August 21, 2024, and elevated its price target to $94. On August 15, 2024, upgrade upgraded it’s rating to Neutral and revised its price target to $90 on the stock. Stifel downgraded its rating to a Hold and decreased its price target to $85 on August 14, 2024. Goldman initiated its recommendation with a Sell and recommended $83 as its price target on May 30, 2024. Robert W. Baird started tracking with a Neutral rating for this stock on July 19, 2023, and assigned it a price target of $90. In a note dated June 30, 2023, CL King initiated an Buy rating and provided a target price of $106 on this stock.
Medtronic Plc [MDT] stock has fluctuated between $75.96 and $92.68 over the past year. Currently, Wall Street analysts expect the stock to reach $95.18 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $85.25 at the most recent close of the market. An investor can expect a potential return of 11.65% based on the average MDT price forecast.
Analyzing the MDT fundamentals
Medtronic Plc [NYSE:MDT] reported sales of 33.00B for the trailing twelve months, which represents a growth of 5.25%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 83.80 points at the first support level, and at 82.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 86.00, and for the 2nd resistance point, it is at 86.76.
Ratios To Look Out For
For context, Medtronic Plc’s Current Ratio is 1.84. As well, the Quick Ratio is 1.39, while the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 3.31, the price to book ratio is 2.25 and price to earnings (TTM) ratio is 26.02.
Transactions by insiders
Recent insider trading involved Wall Brett A., EVP & Pres Neuroscience, that happened on Jan 08 ’25 when 9850.0 shares were sold. Officer, Wall Brett A. completed a deal on Jan 08 ’25 to buy 9850.0 shares. Meanwhile, Former Director PARKHILL KAREN L bought 30000.0 shares on Oct 31 ’24.
